IN2014MN02263A - - Google Patents

Info

Publication number
IN2014MN02263A
IN2014MN02263A IN2263MUN2014A IN2014MN02263A IN 2014MN02263 A IN2014MN02263 A IN 2014MN02263A IN 2263MUN2014 A IN2263MUN2014 A IN 2263MUN2014A IN 2014MN02263 A IN2014MN02263 A IN 2014MN02263A
Authority
IN
India
Prior art keywords
infants
growth
present
sga
insulin
Prior art date
Application number
Other languages
English (en)
Inventor
Naim Shehadeh
Aviv Hanien
Chen Porat
Raanan Shamir
Sebban Lora Eshkar
Michal Devir
Michal Olshansky
Original Assignee
Nutrinia Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrinia Ltd filed Critical Nutrinia Ltd
Publication of IN2014MN02263A publication Critical patent/IN2014MN02263A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Diabetes (AREA)
  • Pediatric Medicine (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
IN2263MUN2014 2012-04-18 2013-04-17 IN2014MN02263A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261625697P 2012-04-18 2012-04-18
PCT/IL2013/050333 WO2013157003A1 (en) 2012-04-18 2013-04-17 Growth enhancement of infants

Publications (1)

Publication Number Publication Date
IN2014MN02263A true IN2014MN02263A (es) 2015-10-09

Family

ID=49383022

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2263MUN2014 IN2014MN02263A (es) 2012-04-18 2013-04-17

Country Status (12)

Country Link
US (1) US20150086622A1 (es)
EP (1) EP2838553A4 (es)
JP (1) JP6177310B2 (es)
CN (2) CN104582716A (es)
AU (1) AU2013250712B9 (es)
CA (1) CA2870091A1 (es)
HK (1) HK1209640A1 (es)
IL (1) IL235074A0 (es)
IN (1) IN2014MN02263A (es)
MX (1) MX2014012671A (es)
RU (1) RU2014145439A (es)
WO (1) WO2013157003A1 (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2018011512A (es) 2016-03-24 2019-02-07 Nutrinia Ltd Uso de insulina para promover el vaciamiento gástrico.
US10993970B2 (en) 2016-12-19 2021-05-04 Hany Z. ALY Medical-grade honey for growth enhancement of infants
US10467147B1 (en) 2017-04-28 2019-11-05 Snap Inc. Precaching unlockable data elements
EP3427725A1 (en) * 2017-07-12 2019-01-16 Roquette Freres Cross-linked maltodextrins for the oral delivery of biological actives

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE413889T1 (de) * 1998-06-05 2008-11-15 Nutrinia Ltd Insulin angereichertes säuglingsnährpräparat
US6399090B1 (en) * 1998-06-05 2002-06-04 Insotech Ltd. Insulin supplemented infant formula
JP2000050793A (ja) * 1998-08-07 2000-02-22 Meiji Milk Prod Co Ltd 人工乳組成物
RU2006101616A (ru) * 2003-06-20 2006-07-27 Ньютриниа Лтд. (Il) Способ защиты биоактивных соединений и композиции, содержащие указанные соединения
GB0502795D0 (en) * 2005-02-10 2005-03-16 Univ Cambridge Tech Treatment of very low birthweight (vlbw) infants
EP2722054B1 (en) * 2005-09-06 2018-03-21 Oramed Pharmaceuticals Inc. Methods and compositions for oral administration of proteins

Also Published As

Publication number Publication date
JP6177310B2 (ja) 2017-08-09
CA2870091A1 (en) 2013-10-24
AU2013250712B2 (en) 2017-12-07
RU2014145439A (ru) 2016-06-10
MX2014012671A (es) 2015-06-05
IL235074A0 (en) 2014-12-31
AU2013250712B9 (en) 2017-12-14
WO2013157003A1 (en) 2013-10-24
CN104582716A (zh) 2015-04-29
JP2015514747A (ja) 2015-05-21
EP2838553A1 (en) 2015-02-25
CN113080448A (zh) 2021-07-09
EP2838553A4 (en) 2015-09-23
US20150086622A1 (en) 2015-03-26
HK1209640A1 (en) 2016-04-08

Similar Documents

Publication Publication Date Title
IN2014DN09782A (es)
TN2015000185A1 (en) 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives containing a sulfoximine group
IN2015DN01156A (es)
NZ709059A (en) Immunotherapy with binding agents
MX354988B (es) Formulaciones de anticuerpo y metodos.
MX365650B (es) Composiciones de amantadina y metodos para su uso.
ZA201304868B (en) Treatment of pain associated with dislocation of basal endometrium
ZA201301234B (en) Methods of reducing blood lactate concentration
TN2015000186A1 (en) N-(pyridin-2-yl)pyrimidin-4-amine derivatives containing a sulfoximine group
MX2013012233A (es) 4-aril-n-fenil-1,3,5-triazin-2-aminas sustituidas.
MX340147B (es) Composiciones farmacéuticas y nutracéuticas del ácido abscísico.
PL2841549T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
PL2841548T3 (pl) Preparaty, ich zastosowanie jako środków do zmywania naczyń lub do wytwarzania środków do zmywania naczyń i ich wytwarzanie
GB2518801B (en) Improvements in, or relating to, caskets or coffins
IN2014MN02263A (es)
IN2015DN00085A (es)
MX347541B (es) Analogos de acido sialico.
NZ626540A (en) Glutamine enriched nutritional composition for preterm infants
WO2013126015A8 (en) Composition comprising non- digestible oligosaccharides
HK1203038A1 (en) Use of reduced calorie infant formula containing nucleotides and or carotenoids for reducing adverse health effects later in life
PH12014501569A1 (en) Glutamine enriched nutritional composition for preterm infants
MX351994B (es) Formas cristalinas de [(s)-1-carbamoil-2-(feniil-pirimidin-2-il-am ino)-etil]-amida del acido 2-(2-metilamino-pirimidin-4-il)-1h-indo l-5-carboxilico.
UA66925U (en) orthopedic spinal support
IL227580A0 (en) Use of hgh to treat toddlers less than two years of age who are small in relation to the age of progression
UA67357U (ru) Способ восстановления зубного ряда при малых дефектах